Woodley Equipment to Attend Global Site Solutions Summit, Florida, USA
October 2, 2015Manufacturing and Production, Research and Development woodley equipment
Woodley Equipment will attend the upcoming Global Site Solutions Summit in Florida, USAThe Global Site Solutions Summit is taking place …
Home Secretary Theresa May opens Abbvie’s new UK offices
October 2, 2015Medical Communications AbbVie
AbbVie today opened new UK offices, in a ceremony presided over by Theresa May, Home Secretary and MP for Maidenhead.The company, …
Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist
October 2, 2015Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough
Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …
Genzyme opts into Alnylam’s Thrombosis program
October 2, 2015Medical Communications, Research and Development Alnylam, Genzyme, Sanofi, haemophilia
Sanofi subsidiary Genzyme has elected to opt into Alnylam’s investigational ALN-AT3 hemophilia program for development and potential future commercialisation in …
Legal analysis: a summary of the Lyrica pregabalin case and the issue of cross-label use in Europe
October 2, 2015Medical Communications Lyrica, Pfizer
The Warner Lambert v Actavis pregabalin cases have been before the UK Courts on no less than seven occasions since the beginning of …
Survey finds GPs have negative views of pharma
October 2, 2015Medical Communications
A survey by healthcare data and intelligence provider Binley’s has found that more than 40% of GPs have a negative …
FDA accepts Sandoz submission for Amgen biosimilar
October 2, 2015Medical Communications, Research and Development Amgen, FDA, Novartis, Sandoz, biosimilars
Sandoz, a Novartis company and a global leader in biosimilars, has announced today that the US Food and Drug Administration …
Berg joins Genomics England project to sequence 100,000 genomes
October 2, 2015Medical Communications, Research and Development Berg, Genomics england, artificial intelligence
Boston-based biopharmaceutical company Berg has announced it will join an industry collaboration with Genomics England, with the goal of sequencing …
CEO Stephen Whitehead leaves ABPI
October 1, 2015Medical Communications ABPI, Alison Clough, Stephen Whitehead
The ABPI has confirmed that CEO Stephen Whitehead has left the organisation. Speaking on behalf of the Board, John Kearney, …
Dr Karen Bernstein joins Ovid and Vitae boards
October 1, 2015Medical Communications, Sales and Marketing Dr Karen Bernstein, Ovid Therapeutics, Vitae Pharmaceuticals
Ovid Therapeutics has announced the appointment of Karen Bernstein to the company’s Board of Directors. Dr Bernstein says: “I have …
Verona Pharma’s respiratory drug proves positive in study
October 1, 2015Research and Development COPD, verona pharma
Verona Pharma has announced encouraging positive headline data of the third and final part of a randomised, clinical study in …
Quick test minimises unnecessary antibiotic prescribing
October 1, 2015Medical Communications antibiotic resistance
New data presented at this week’s Royal College of General Practitioners (RCGP) Annual Conference reveals that in real-world general practice, …
Novartis’s secukinumab meets Phase 3 goals
October 1, 2015Research and Development Novartis, Secukinumab, arthritis
Novartis has announced that its secukinumab medication for treatment of psoriatic arthritis (PsA), met its primary endpoint in the pivotal …
Pfizer’s self-injectable contraceptive becomes UK’s first
September 30, 2015Medical Communications, Research and Development, Sales and Marketing Pfizer, Syayana Press
Pfizer’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the UK for administration by self-injection following …
Study shows Novartis’s Afinitor positively reduces tumors
September 30, 2015Research and Development Afinitor, Novartis
Novartis has announced the results of a Phase III pivotal study, showing Afinitor (everolimus) tablets reduced the risk of progression …
Genentech’s ocrelizumab shows efficacy in phase III trial
September 30, 2015Research and Development Genentech, MS, Roche, ocrelizumab
Roche subsidiary Genentech has announced positive results from a pivotal phase III study of its investigational medicine ocrelizumab in people …
Heptares awarded $5.5 million grant to combat cocaine addiction
September 30, 2015Research and Development Heptares
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, has been awarded a grant from the National Institute …
Roche says Esbriet shown to extend lives of IPF patients
September 30, 2015Medical Communications, Research and Development, Sales and Marketing Esbriet, Roche, idiopathic pulmonary fibrosis
Roche has presented new clinical data and abstracts on Esbriet (pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF), showing …
Featured market report: US pharmaceutical market to 2018
September 29, 2015Manufacturing and Production, Sales and Marketing market reports
This report forecasts US pharmaceutical (prescription and over-the-counter) shipments and demand at the manufacturers’ level, to 2018.This industry forecast report …
New study reveals true impact of severe asthma in Europe
September 29, 2015Research and Development ERS2015, asthma
The results of a new, comprehensive survey have revealed the true burden of severe asthma faced by patients across Europe. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
